Abstract
Echocardiography is an important imaging technique providing real-time imaging that can be performed at the bedside and easily repeated as needed (Table 1). Before the era of highly active anti-retroviral therapy (HAART), cardiac complications in HIV included pericardial effusion, dilated cardiomyopathy, myocarditis, endocarditis, pulmonary hypertension, cardiac neoplasm, coronary artery disease and drug-related cardiotoxicity [1, 2]. Cardiac abnormalities, although usually clinically silent, can be detected in necropsy series in the majority of infected HIV patients (40–60%) [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbaro G (2002) Cardiovascular manifestations of HIV infection. Circulation 106:1420–5
Fisher SD, Lipshultz SE (2001) Epidemiology of cardiovascular involvement in HIV disease and AIDS. Ann NY Acad Sci 946:13–22
Barbaro G (2003) Evolution of the involvement of the cardiovascular system in HIV infection. Adv Cardiol 40:15–22
Barbarini G, Barbaro G (2003) Incidence of the involvement of the cardiovascular system in HIV infection. AIDS 17:S46–50
Reuter H, Burgess LJ, Doubell AF (2005) Epidemiology of pericardial effusions at a large academic hospital in South Africa. Epidemiol Infect 133:393–399
Heidenreich PA, Eisenberg MJ, Kee LL et al (1995) Pericardial effusion in AIDS: incidence and survival. Circulation 92:3229–3234
Chen Y, Brennessel D, Walters J et al (1999) Immunodeficiency virus-associated pericardial effusion: report of 40 cases and review of the literature. Am Heart J 137:516–521
Pugliese A, Isnardi D, Saini A et al (2000) Impact of highly active antiretroviral therapy in HIV-positive patients with cardiac involvement. J Infect 40:282–284
Roy CL, Minor MA, Brookhart MA, Choudhry NK (2007) Does this patient with a pericardial effusion have cardiac tamponade? JAMA 297:1810–1818
Gowda RM, Khan IA, Sacchi TJ, Vasavada BC (2003) Cardiac tamponade in acquired immunodeficiency syndrome. Int J Cardiol 88:313–314
Iacobellis G, Pellicelli AM, Sharma AM et al (2007) Relation of subepicardial adipose tissue to carotid intima-media thickness in patients with human immunodeficiency virus. Am J Cardiol 99:1470–1472
Pinamonti B, Alberti E, Cigalotto A et al (1988) Echocardiographic findings in myocarditis. Am J Cardiol 62:285–289
Camerini F, Bussani R, Lenarda D et al (1991) Clinical aspects and haemodynamics in the followup of dilated cardiomyopathy and myocarditis. Eur Heart J 12(Suppl D):193–196
Hiramitsu S, Morimoto S, Kato S et al (2001) Transient ventricular wall thickening in acute myocarditis: a serial echocardiographic and histopathologic study. Jpn Circ 65:863–866
Lieback E, Hardouin I, Meyer R et al (1996) Clinical value of echocardiographic tissue characterization in the diagnosis of myocarditis. Eur Heart J 17:135–142
Felker GM, Boehmer JP, Hruban RH et al (2000) Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 36:227–232
Mendes LA, Picard MH, Dec GW et al (1999) Ventricular remodeling in active myocarditis: myocarditis treatment trial. Am Heart J 138:303–308
Thuny F, Avierinos JF, Jop B et al (2006) Images in cardiovascular medicine: massive biventricular thrombosis as a consequence of myocarditis: findings from 2-dimensional and real-time 3-dimensional echocardiography. Circulation 113:e932–933
Mendes LA, Dec GW, Picard MH et al (1994) Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 128:301–307
Swedberg K, Cleland J, Dargie H et al (2005) Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26:1115–1140
Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIVpositive patients. Gruppo Italiano per lo Studio Cardiologico dei Pazienti Affetti da AIDS. N Engl J Med 339:1093–1099
Cardoso JS, Moura B, Martins L et al (1998) Left ventricular dysfunction in human immunodeficiency virus (HIV) infected patients. Int J Cardiol 63:37–45
Longo-Mbenza B, Seghers KV, Phuati M et al (1998) Heart involvement and HIV infection in African patients: determinants of survival. Int J Cardiol 64:63–73
Twagirumukiza M, Nkeramihigo E, Seminega B et al (2007) Prevalence of dilated cardiomyopathy in HIV-infected African patients not receiving HAART: a multicenter, observational, prospective, cohort study in Rwanda. Curr HIV Res 5:129–137
Brown DL, Sather S, Cheitlin MD (1993) Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patient. Am Heart J 125:1439–1441
Galia N, Torbicki A, Barst R et al (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension: The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243–2278
Opravil M, Pechere M, Speich R et al (1997) HIV-associated primary pulmonary hypertension: a case control study. Swiss HIV Cohort Study. Am J Respir Crit Care Med 155:990–995
Mesa RA, Edell ES, Dunn WF, Edwards WD (1988) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases. Mayo Clin Proc 73:37–45
Petitpretz P, Brenot F, Azarian R et al (1994) Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 89:2722–2727
Ehrenreich H, Rieckmann P, Sinowatz F et al (1993) Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol 150:4601–4609
Humbert M, Monti G, Fartoukh M et al (1998) Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11:554–559
Mehta NJ, Khan IA, Mehta RN, Sepkowitz DA (2000) HIV-related pulmonary hypertension: analytic review of 131 cases. Chest 118:1133–1141
Zuber JP, Calmy A, Evison JM et al; Swiss HIV Cohort Study Group (2004) Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy. Clin Infect Dis 38:1178–1185
Lang RM, Bierig M, Devereux RB et al (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification. J Am Soc Echocardiogr 18:1440–1463
Martinez-Garcia T, Sobrino JM, Pujol E et al (2000) Ventricular mass and diastolic function in patients infected by the humanimmuno deficiency virus. Heart 84:620–624
Coudray N, de Zuttere D, Force G et al (1995) Ventricular diastolic function in asymptomatic and symptomatic human immunodeficiency virus carriers: an echocardiographic study. Eur Heart J 16:61–67
Samaan SA, Foster A, Raizada V et al (1995) Myocardial atrophy in acquired immunodeficiency syndrome: associated wasting. Am Heart J 130:823–827
Meng Q, Lima JA, Lai H, Vlahov D et al (2002) HIV protease inhibitors is associated with left ventricular morphologic changes and diastolic dysfunction. J Acquir Immune Defic Syndr 30:306–310
Losa JE, Miro JM, Del Rio A et al (2003) Endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clin Microbiol Infect 9:45–54
De Rosa FG, Cicalini S, Canta F et al (2007) Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIVinfected patients. Infection 35:154–160
Gebo KA, Burkey MD, Lucas GM et al (2006) Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort. J Acquir Immune Defic Syndr 43:426–432
Valencia E, Miro J (2004) Endocarditis in the setting of HIV infection. AIDS Rev 6:97–106
Horstkotte D, Follath F, Gutschik E et al (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary: the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25:267–276
Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA; HIV/AIDS Cancer Match Study (2007) AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst 99:962–972
Khan NU, Ahmed S, Wagner P et al (2004) Cardiac involvement in non-Hodgkin’s lymphoma: with and without HIV infection. Int J Cardiovasc Imaging 20:477–481
Iwahashi N, Nakatani S, Kakuchi H et al (2005) Cardiac tumor as an initial manifestation of acquired immunodeficiency syndrome. Circ J 69:243–245
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Italia
About this chapter
Cite this chapter
Ederhy, S., Meuleman, C., Haddour, N., Dufaitre, G., Boccara, F., Cohen, A. (2009). Echocardiographic Findings in HIV-Infected Patients. In: Barbaro, G., Boccara, F. (eds) Cardiovascular Disease in AIDS. Springer, Milano. https://doi.org/10.1007/978-88-470-0761-1_6
Download citation
DOI: https://doi.org/10.1007/978-88-470-0761-1_6
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0760-4
Online ISBN: 978-88-470-0761-1
eBook Packages: MedicineMedicine (R0)